Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
NCT ID: NCT00530335
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00530335
Study Brief: Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Atomoxetine 40 mg/day every, by mouth, for 1 week; 80 mg/day every day, by mouth, for 1 week; 105 mg/day every day, by mouth, for 2 weeks; 120 mg/day every day, by mouth, for 4 weeks None None 0 45 45 45 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MEDDRA (11.0) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA (11.0) View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA (11.0) View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA (11.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA (11.0) View
Stomach discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA (11.0) View
Malaise SYSTEMATIC_ASSESSMENT General disorders MEDDRA (11.0) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MEDDRA (11.0) View
Thirst SYSTEMATIC_ASSESSMENT General disorders MEDDRA (11.0) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MEDDRA (11.0) View
Electrocardiogram QT prolonged SYSTEMATIC_ASSESSMENT Investigations MEDDRA (11.0) View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations MEDDRA (11.0) View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MEDDRA (11.0) View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MEDDRA (11.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA (11.0) View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA (11.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA (11.0) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA (11.0) View
Tremor SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA (11.0) View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MEDDRA (11.0) View
Middle insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MEDDRA (11.0) View
Dysuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MEDDRA (11.0) View
Dysmenorrhoea SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MEDDRA (11.0) View
Hot flush SYSTEMATIC_ASSESSMENT Vascular disorders MEDDRA (11.0) View